Vaccinia (VACV) and Cowpox (CPXV) viruses belong to the Poxviridae family, genus Orthopoxvirus. Poxviruses are linear double-stranded DNA viruses that encode more than 200 genes, most of them associated with virus-host interactions and suppression or modulation of host immune response in order to facilitate viral replication. VACV is the prototype of the family and has been vastly studied in the past decades. On the other hand, VACV and CPXV are not only phylogenetically close, but they also share their ability to infect a wide range of hosts, such as humans, cows, rodents and zoo animals. And historically, both VACV and CPXV were involved in the practice of human vaccination against smallpox, a deadly disease caused by Variola virus, which was successfully declared eradicated by the World Health Organization in 1980 ([@B10], [@B44]). Since its eradication, humans stopped being vaccinated and an increasing number of outbreaks in both human and animals caused by poxviruses have been reported in the past years in Brazil, Europe and United States of America ([@B19], [@B12], [@B53], [@B58], [@B67], [@B68], [@B01], [@B20]).

Until this date, it is still intriguing and fascinating how poxviruses and many other viruses have evolved strategies to manipulate host cells by activating, up or down-regulating a variety of cellular signalling pathways to favour a successful infection. For instance, mitogen activated protein kinase (MAPK) cascades are evolutionary conserved enzymes connecting cell-surface receptors to critical regulatory targets within cells leading to responses as diverse as proliferation, differentiation, immune response and cell death ([@B08], [@B45], [@B15], [@B06]). The phosphoinositide-3 kinase (PI3K) pathway is another important cell signalling pathway that also regulates a variety of cellular activities including cell growth, proliferation, survival and movement ([@B28]). Therefore, over the years many studies have shown great examples of how viruses manipulate cellular signalling pathways. For instance, activation of the MAPKs MEK/ERK and JNK1/2 is required for productive infection of baculovirus ([@B36]). The MAPK-ERK pathway was also shown to play an important role in regulating gene expression and replication of hepatitis C virus (HCV) ([@B46]) and Kaposi\'s sarcoma-associated herpesvirus ([@B60]). Many other studies have reported the activation and significance of MAPK JNK pathway for viruses such as influenza ([@B40] ), rotavirus ([@B31]) and herpesvirus ([@B09], [@B49], [@B26], [@B73]). In addition, the role of PI3K/Akt pathway in viral replication has been described for herpesvirus ([@B51] ), flaviviruses ([@B37]), HCV ([@B29]), coxsackievirus B3 ([@B16]), influenza ([@B61]), human immunodeficiency virus type 1 (HIV-1) ([@B71]).

In the past decade, our group has shown that VACV and CPXV also stimulate MEK/ERK/1/2/Egr-1 cascade as well as JNK1/2 and PI3K/Akt pathways during infection. Furthermore, our results have demonstrated that these two closely phylogenetic related viruses are able to activate the same signalling pathways upon infection; however, those pathways seem to have a different role in each case. For example, inhibition of MEK/ERK/Egr-1 cascade impairs VACV replication, but has no impact upon CPXV replication (de Magalhães et al. 2001, [@B03], [@B62]). On the other hand, host survival and viral replication require the activation of the PI3K/Akt pathway after infection for both VACV and CPXV ([@B63]). Moreover, we have recently demonstrated that JNK1/2 is abundantly activated at late times during infection and it plays a role in VACV exit and spread (Pereira et al. 2012a, b).

Rho GTPases belong to the Ras superfamily of small GTPases and are also highly conserved throughout eukaryotes with Rho, Rac1 and Cdc42 being the far best characterised members ([@B24]). The Rho GTPases function as molecular switches and cycle between an active GTP-bound state and an inactive GDP-bound state. In cells, Rho GTPases exist mainly in their inactive form ( [@B23], [@B54], [@B30]). Activation is mediated by guanine nucleotide exchange factors, while GTPase-activating proteins promote the hydrolysis of GTP to GDP. When bound to GTP, the Rho proteins can activate various downstream effectors, thereby stimulating diverse biological responses, such as actin dynamics, cell cycle progression, cell adhesion, cytoskeletal reorganisation, cellular growth, apoptosis, gene transcription, cell polarity, migration, vesicle trafficking and cytokinesis ([@B04], [@B30]). Recent studies have showed that Rac1 GTPase is important for many virus infections such as Herpes simplex virus 1 ([@B32]), HIV-1 ([@B50]), hepatitis B virus (HBV) ([@B11]), Coxsackievirus ([@B65]), African swine fever virus ( [@B52]) and dengue virus ( [@B72], [@B69]). In addition, early and recent studies have shown that VACV activates Rac1 in early times during infection and contributes to viral entry ([@B39], [@B41]); however, not much is known whether activation of Rac1 is associated to stimulation of the MAPK ERK and JNK and/or Akt pathways. Evidences for extensive cooperation and cross talk between GTPases and others signalling pathways are well documented in many systems ([@B14], [@B66], [@B18], [@B43], [@B25], [@B17], [@B64], [@B07], [@B34], [@B59], [@B02]), including viral infection. For example, Rac1 activation by HBV replication resulted in the phospho-rylation of ERK1/2 and Akt ([@B65]). Rac1 was also found to be an important downstream effector in the entry regulation of Ebola virus. Inhibition of PI3K-Akt-Rac1 pathway disrupted normal uptake of virus particles into cells ([@B55]) and so on.

Taking these into consideration, the goal of the present work was to examine whether the GTPase Rac1 was a component of the cellular signalling pathways activated during VACV or CPXV\' infections. Therefore, we have generated stable murine fibroblasts exhibiting negative dominance for Rac1-N17 in order to evaluate viral growth as well as the phosphorylation status of ERK1/2, JNK1/2 and Akt.

MATERIALS AND METHODS
=====================

*Cell culture, antibodies and chemicals* - A31 cells (a clone derived from mouse BALB/c 3T3) and Vero cells were cultured in Dulbecco\'s modified Eagle\'s medium supplemented with 7.5% and 5% heat-inactivated foetal bovine serum (FBS) (Cultilab, Campinas, Brazil), respectively, and antibiotics in 5% CO~2~ at 37°C. The antibodies anti-phospho-JNK/SAPK (Thr183/Tyr185), anti-phospho-ERK1/2 (Thr202/Tyr204), anti-phospho-Akt (Ser473), anti-total ERK1/2 and the horse radish peroxidase (HRP) conjugated anti-rabbit and anti-mouse secondary antibodies were purchased from Cell Signaling Technology, Beverly, MA, USA. The anti β-actin antibody was purchased from Sigma-Aldrich, São Paulo, Brazil. The specific antibodies for the viral H3L and SPI-2/CrmA proteins were a generous gift from B Moss (NIAID, Bethesda, MD) and D Pickup (Duke University Medical Center, Durham, NC), respectively. Geneticin (G418) was purchased from Invitrogen, São Paulo, Brazil.

*Generation of Rac1 dominant-negative (DN)* *(Rac1-N17) cells* - Murine fibroblasts stably displaying DN for the mutant Rac1 (T17N) were generated by transfecting A31 cells with 10 μg of either pCDNA3 plasmid carrying Rac1 insert (Guthrie cDNA Company Resource Center) or with the empty vector (kindly provided by Dr Oscar Bruña Romero, Federal University of Minas Gerais, Brazil) using standard calcium phosphate protocol ([@B56]). Transfectants were ring cloned after a selection with 800 μg/mL G418 for at least 21 days. Then, the selected clones were expanded and G418 was kept at 200 μg/mL. In order to confirm positive G418-resistant clones DNA extractions were performed by phenol-chloroform and the Rac1 (T17N) gene fragment was amplified by touchdown polymerase chain reaction (PCR), using the pcDNA3.1 vector primers (T7 forward: 5\'-TAATACGACTCACTATAGGG-3\' and BGH reverse: 5\'-TAGAAGGCACAGTCGAGGC-3\'). Amplicons were gel-purified using Wizard^(r)^ SV Gel and PCR Clean-Up System (Promega), then they were cloned into pGEM-T^(r)^ Easy Vector Systems (Promega) and transformed in *Escherichia coli* M15. Colonies were picked to confirm the presence of the DN mutation of Rac1 for each G418-resistant A31 clones. Briefly, minipreps were performed by PureYield™ Plasmid Miniprep System (Promega) and DNA samples were sequenced using the pGEM-T^(r)^ Easy Vector Systems primer (M13) (Promega) and MegaBACE 1000 capillary sequencer (GE Healthcare, United Kingdom).

*Cell growth curves* - A31 cells and clones carrying DN Rac1-N17 or empty vector were cultured in 35 mm dishes at a density of 1 x 10^5^ cells in 7.5% serum. At the times of 24 h, 48 h and 72 h, cells were washed with room temperature (RT) phosphate-buffered saline (PBS), trypsinised and counted using the Neubauer chamber to calculate cellular growth. Data were confirmed by at least three independent experiments with similar results.

*Viruses -* For viral stocks, the wild-type VACV (strain WR) and CPXV (strain BR) viruses were propagated in Vero cells. Viruses were then highly purified by sucrose gradient sedimentation as described ([@B35]). For viral infections in both A31 and DN Rac1-N17 cells lines, cells were counted before seeding them as well as before infection to assure similar number between cell lines. Then, cells were starved by changing the media to 1% FBS and incubated for 12 h. Cells were infected at the indicated multiplicity of infection (MOI) for the times shown.

*Multi-step viral growth curves -* Thirty-five millimetres dishes of A31 or DN Rac1-N17 cells lines at a density of 5 x 10^5^ cells were starved with 1% FBS media for 12 h and then infected at a MOI of 10 for 3 h, 6 h, 12 h, 24 h, 36 h and 48 h. After 1 h adsorption at 37°C, viral inoculum was aspirated and cells were fed and kept at 1% FBS media. At each time point, cultures were washed with cold PBS and cells were disrupted by three freezing/thawing cycles. Supernatants were collected and viral yields were quantified by viral plaque assay as described ([@B05]). Data were confirmed by at least three independent experiments with similar results.

*Lysate preparation, electrophoresis and immunoblotting -* A31 and DN Rac1-N17 cells were cultured in 60 mm dishes at the density of 7.5 x 10^5^ and starved for 12 h followed by infection with either VACV or CPXV at indicated MOI and time. At each time, for whole cell lysates cells were washed with cold PBS and disrupted on ice with lysis buffer \[100mM Tris-HCl (pH 8.0), 1% Triton X-100, 0.2mM ethylenediamine tetraacetic acid (EDTA), 20% glycerol (v/v), 200mM NaCl, 1mM sodium orthovanadate, 1mM phenylmethanesulfonyl fluoride (PMSF), 5μg/mL aprotinin, 2.5μg/mL leupeptin, 1mM dithiothreitol (DTT)\]. Whole cell lysates were collected by centrifugation at 13,500 rpm for 15 min at 4°C. For nuclear lysates, cells were scraped from the dish and spun at 3,000 rpm for 3 min at 4°C. Then, pellets were ressuspended in hypotonic buffer (10mM HEPES pH 7.9, 10mM KCL, 0.2mM EDTA and 1mM DTT) and incubated on ice for 5 min followed by centrifugation at 2,000 rpm for 2 min. Supernatants were discarded and nuclei pellets were ressuspended in lysis buffer (20mM HEPES pH 7.9, 0.42M NaCl, 2mM EDTA and 1mM DTT, 1mM PMSF, 5μg/mL aprotinin, 2.5μg/mL leupeptin) and incubated on ice for 30 min. Finally, samples were centrifuged at 12,000 rpm for 15 min at 4°C and supernatants were saved and stored at -70°C. Protein concentration was determined by the Bio-Rad assay (Bio-Rad Laboratories, USA). Fifteen (nuclear cell lysates) to 30 µg (whole cell lysates) of protein per sample were separated by electrophoresis on a 10% sodium dodecyl sulphate polyacrylamide gel and transferred to nitrocellulose membranes as previously described (de Magalhães et al. 2001). Briefly, membranes were blocked at RT for 1 h with PBS containing 0.1% Tween-20 and 5% (w/v) non-fat milk. The membranes were washed three times with PBS containing 0.1% Tween-20, incubated with specific polyclonal or monoclonal antibody (1:1,000-1:3,000) in PBS containing 0.1% Tween-20 and 5% (w/v) bovine serum albumin, followed by incubation with the HRP-conjugated secondary anti-rabbit or anti-mouse antibody Ab. Immunoreactive bands were visualised by the ECL Detection System as described in the manufacturer\'s instructions (GE Healthcare, UK).

*Virus plaque phenotype -* A31 and DN Rac1-N17 cells were cultured in 35 mm dishes, starved and infected with either VACV or CPXV at 100 plaque forming units/dish. After 1 h adsorption at 37°C, inoculum was aspirated and cells were fed with semi-solid medium containing 0.5% agarose. After 48 h cells were fixed and stained with 10% formaldehyde/0.3% (wt/vol) crystal violet solution.

RESULTS
=======

*Cell growth evaluation of murine fibroblasts displaying DN for Rac1-N17 -* To uncover whether Rac1 GTPase is part of the signalling pathways activated by VACV and CPXV infections we have generated stable murine fibroblasts that displays a DN form of Rac1 (DN Rac1); there is a mutation on the threonine residue (position 17) to asparagine, which unable its phosphorylation and function. Therefore, we first performed cellular growth curves of A31 cells and DN Rac1-N17 cell lines (clones 3 and 6). As shown in [Fig. 1](#f01){ref-type="fig"}, our results demonstrate that the DN of Rac1 did not affect cellular growth; either clone 3 (dark grey bars) or 6 (black bars) grew at similar levels as A31 cells (white bars) or cells carrying the empty vector (light grey bars).

Fig. 1murine fibroblasts displaying negative dominance for Rac1-N17 grow at similar levels as the wild-type cells. A31 wild-type cells (white bars), dominant-negative (DN) Rac1-N17 cells (clones 3 or 6, dark grey and black bars, respectively) and cells carrying an empty vector pcDNA3 (light grey bars) were cultured in 35 mm dishes starting at 1 x 10^5^ cells in 7.5% serum. At the times of 24 h, 48 h and 72 h cells were counted using a Neubauer chamber to calculate cellular growth. At least three independent experiments were performed with similar results, but the most representative curve is shown.

*VACV replication, but not CPXV, is compromised in DN cells for Rac1-N17 -* Our next step was to investigate the impact of the DN of Rac1-N17 upon VACV and CPXV\' replication. In order to do that, we performed viral growth curves and measured virus production. Our results show that viral yield was greatly reduced for VACV in about 1 log ([Fig. 2A](#f02){ref-type="fig"}) when compared to A31 cells, while CPXV had comparable yield in both cells lines ( [Fig. 2B](#f02){ref-type="fig"}). Experiments were also performed in cells carrying the empty vector and viral yield for both VACV and CPXV were also similar to A31 cells (data not shown). Furthermore, we examined VACV and CPXV plaque phenotype; as shown in [Fig. 2C](#f02){ref-type="fig"}, the plaque size for VACV was considerably smaller (top circles) in the DN Rac1-N17 cells, whereas for CPXV no major changes in the plaque size were observed when compared to A31 cells (bottom circles). These results suggest that Rac1 may not play an important role for CPXV biology as it is indicative for VACV.

Fig. 2Vaccinia virus (VACV) but not Cowpox virus (CPXV) replication is impaired in Rac1-N17 dominant-negative (DN) cells. Viral growths were evaluated in either A31 wild-type cells or DN Rac1-N17 (clones 3 or 6). Cells were serum starved for 12 h prior infection with either VACV (A) or CPXV (B) at a multiplicity of infection of 10; at the time points of 3 h post-infection (hpi), 6 hpi, 12 hpi, 24 hpi, 36 hpi and 48 hpi cells were harvested to measure viral yields. At least three independent experiments were performed with similar results (C). Plaque phenotype of VACV (top) or CPXV (bottom) in either A31or DN Rac1-N17 cells. Confluent cell monolayers were serum starved for 12 h followed by infection with VACV or CPXV at 100 plaque forming units (PFU). Cells were stained with 10% formaldehyde/0.3% crystal violet solution at 48 hpi.

*Analysis of viral gene expression in DN Rac1-N17 cells -* Bearing in mind that we observed a decrease in VACV production, further analyses were performed to investigate if viral early and late gene expression were compromised as well. For that, A31 or DN Rac1-N17 cells were left uninfected (MOCK) or infected with VACV (MOI of 10) and harvested from 3-36 h post-infection (hpi), followed by western blot analyses for either the early viral protein SPI-2 or the late viral protein H3. Our results demonstrate that viral early gene expression displayed comparable levels between A31 and DN Rac1-N17 cells ([Fig. 3A](#f03){ref-type="fig"}, D, respectively). On the other hand, viral late gene expression was delayed in the DN Rac1-N17 cells comparing to A31 cells ([Fig. 3E](#f03){ref-type="fig"}, B, Lanes 3-7, respectively). As expected, no difference in viral gene expression was observed in cells carrying the empty vector when compared to A31 cells (data not shown). Infections with CPXV were also made in parallel and early and late viral gene expression exhibited equivalent levels in A31 and DN Rac1-N17 cells (data not shown) ([Fig. 3G](#f03){ref-type="fig"}, I, Lanes 3-7).

Fig. 3analysis of viral gene expression in A31 Rac1-N17 dominant-negative (DN) cells upon Vaccinia virus (VACV) and Cowpox virus (CPXV) infection. A31 (A-C, G, H) and DN Rac1-N17 (D-F, I, J) cells were serum starved for 12 h prior infection with VACV or CPXV at a multiplicity of infection (MOI) of 10. At the various time points shown, cell lysates were harvested and analysed by Western blotting using antibodies raised against the viral proteins CrmA (SPI-2) (A, D) or H3L (B, E, G, I). Anti-total ERK1/2 antibody (C, F) or anti-β-actin antibody (H, J) were used as internal controls for protein loading. Molecular masses (in kDa) are indicated on the left. hpi: hours post-infection.

*Phosphorylation of ERK1/2 is Rac1-independent during VACV infection -* We have shown that VACV infection can promote the phosphorylation of MAPK ERK1/2; a sustained activation was observed starting at 5 min post-infection (de Magalhães et al. 2001) until 8 hpi ([@B03]). Intending to better characterise the components of the signalling pathways activated by VACV infection, we evaluated whether ERK1/2 phosphorylation status was affected by the DN of Rac1-N17. For this purpose, A31 or DN Rac1-N17 cells were infected with VACV (MOI of 10) and harvested at 4 hpi for immunoblot analysis. As shown in [Fig. 4](#f04){ref-type="fig"}, phosphorylation of ERK1/2 presented similar levels in A31 cells and DN Rac1-N17 (clones 3 and 6) (compare Lanes 2, 4 and 6). Our data indicate that ERK1/2 activation upon VACV infection is independent of Rac1.

Fig. 4ERK1/2 activation by Vaccinia virus (VACV) infection is Rac1-independent. A31 and dominant-negative (DN) Rac1-N17 cells were serum starved for 12 h and then infected with VACV at a multiplicity of infection of 10. At 4 h post-infection (hpi), cell lysates were collected and the phosphorylation status of ERK1/2 was analysed by Western blotting. Anti-total ERK1/2 antibody was used as an internal control for protein loading. Molecular masses (in kDa) are indicated on the left.

*Akt phosphorylation is reduced in DN Rac1-N17 cells upon VACV infection -* Our previous studies have also shown that VACV activates the PI3K/Akt signalling pathway in early and late times during infection and when this cascade is inhibited, viral yield is dramatically reduced ([@B63]). Here we evaluated whether Rac1 would participate in this signalling pathway. To address that, A31 or DN Rac1-N17 cells were left uninfected (MOCK) or infected with VACV, MOI of 10; cells were harvested at 30 min, 1 hpi, 3 hpi, 24 hpi and 30 hpi, in which cell lysates were collected and subjected to immunoblot analysis. Our results demonstrate that Akt phosphorylation was greatly delayed, particularly at early times during infection ([Fig. 5A](#f05){ref-type="fig"}, B, Lanes 3-7). In contrast, DN of Rac1-N17 upon CPXV infection did not affect Akt phosphorylation ([Fig. 5C](#f05){ref-type="fig"}, D, Lanes 2-4).

Fig. 5Akt phosphorylation is affected in A31 Rac1-N17 dominant-negative (DN) cells only upon Vaccinia virus (VACV) infection. A31 (A, C) and DN Rac1-N17 (B, D) cells were serum starved for 12 h prior infection with VACV or Cowpox virus (CPXV) at a multiplicity of infection (MOI) of 10. At the various time points shown, cell lysates were collected and the phosphorylation status of Akt was analysed by Western blotting. Anti-β-actin antibody was used as an internal control for protein loading. Molecular masses (in kDa) are indicated on the left. hpi: hours post-infection.

*Examination of JNK1/2 activation during VACV and CPXV infection -* GTP-binding proteins controlling the enzymatic activity of MAPKs such as JNK has been described ([@B57], [@B66]). Recently, we have demonstrated that VACV induces JNK1/2 activation, mostly at late times during infection, with a role in viral exit and spread (Pereira et al. 2012a, b). Therefore, we decided to investigate whether phosphorylation of JNK was affected by the DN of Rac1-N17. For that, A31 or DN Rac1-N17 cells were left uninfected (MOCK) or infected with VACV (MOI of 10) from 3-42 h. At each time, cells were harvested and cell lysates were used for western blot analysis using specific anti-phospho JNK1/2 antibody. As shown in [Fig. 6A](#f06){ref-type="fig"}, VACV infection leads to activation of JNK1/2 during its whole life cycle, with a robust increase in the levels of JNK1/2 phosphorylation from 12-42 hpi (Lanes 3-8). On the other hand, our results show a noteworthy difference in JNK1/2 pattern of phosphorylation when we compare VACV-infected DN Rac1-N17 to wild-type A31 cells; phosphorylation of JNK1/2 can be detected at early times as 3 hpi in A31 cells while similar levels are detected only from 24 hpi in DN Rac1-N17 cells ([Fig. 6A](#f06){ref-type="fig"}, C, Lanes 3-8). Unlike VACV, infection with CPXV presented equal levels of JNK phosphorylation in DN Rac1-N17 and A31 cells ([Fig. 6E](#f06){ref-type="fig"}, Lanes 2, 4, 6).

Fig. 6examination of JNK1/2 activation during Vaccinia virus (VACV) and Cowpox virus (CPXV) infection. A31 and dominant-negative (DN) Rac1-N17 cells were serum starved for 12 h and then infected with VACV or CPXV at a multiplicity of infection (MOI) of 10. At the various time points indicated (for VACV) or 12 h post-infection (hpi) (for CPXV), cell lysates were collected to investigate JNK1/2 phosphorylation status (A, C, E) by Western blotting. Anti-β-actin antibody was used as an internal control for protein loading (B, D, F). Molecular masses (in kDa) are indicated on the left.

DISCUSSION
==========

The interaction of viruses with cell surface receptors can elicit two types of signals, conformational changes of viral particles and intracellular signals triggering specific cellular reactions, such as the immune response. As a result, many viruses have evolved strategies to counteract cellular signalling pathways to efficiently produce viral progeny ([@B21]).

We have shown previously that the orthopoxviruses VACV and CPXV, which are phylogenetically close, activate the same signalling cascades such as MEK1/2/ERK1/2/Egr-1; however, while the stimulation of this pathway is beneficial for VACV replication, the biological significance for CPXV life cycle is still not elucidated ([@B03], [@B62]). In contrast, blocking of PI3K/Akt cascade reduced dramatically viral yield for both viruses ([@B63]).

The GTPase Rac1 is a component of the cellular signalling pathways that is activated at early times (up to 1 h) during VACV infection, playing a role in viral entry by acting upstream of PAK1 ([@B39], [@B41]); however, it is unknown whether Rac1 participates in the previously characterised signalling pathways stimulated upon VACV and CPXV\' infection. Therefore, in the present work we investigated the impact of the DN of Rac1-N17 during viral replication.

Our results demonstrated, as expected, that the DN of Rac1-N17 did not affect cell growth when compared to both parental A31 cells and cells carrying the empty vector. On the other hand, we demonstrated that only VACV replication was impaired by the DN of Rac1-N17, resulting in viral plaques with reduced sizes, whereas for CPXV, no major differences were observed. This was further confirmed when viral protein accumulation was analysed. Only late protein accumulation, exemplified by H3L, was greatly inhibited only during VACV infection of Rac1-N17 DN cells, corroborating the defect found in VACV progeny production in those cells. These findings indicated that Rac1 GTPase plays a role during VACV infection, but the same is not valid for CPXV infection, at least in regard to progeny generation and dissemination.

We also provide evidence that Rac1 is not a component of the MEK1/2/ERK1/2 pathway during VACV infection. However, our data indicates that Rac1 participates in the signalling pathway of PI3K leading to the activation of Akt, but it is unclear whether Rac1 is upstream or downstream of PI3K. In both situations, Akt is a key signalling switch downstream from both PI3K and Rac1. Many studies have shown PI3K as an upstream regulator of Rac1 in systems others than viral infection ( [@B33], [@B42], [@B70], [@B22]), but the opposite has also been reported ([@B27], [@B38]).

Previously, we have demonstrated that inhibition of PI3K by its highly selective inhibitor LY294002 abolishes Akt phosphorylation upon either VACV or CPXV infections ([@B63]) and few hpi cells undergo apoptosis. In the present work, we did not observe any morphological signs of cell death or apoptosis in cells displaying DN for Rac1-N17. For that reason, our results suggest that the minimum levels of Akt phosphorylation detected in infected DN Rac1-N17 cells at early times may be enough to trigger survival signals to keep cells alive for few hours while virus replicates, although they may be not sufficient to generate an appropriate environment for a successful virus production.

We also find that Rac1 is a component of the JNK1/2 pathway during VACV infection, but the same was not observed for CPXV. We recently documented that VACV replication is not affected when infection takes place in JNK1/2-deficient murine fibroblasts; however, viral exit and spread is deregulated leading to viral plaques of augmented size and to an increase in the formation and release of cell-associated enveloped virus and extracellular enveloped virus (Pereira et al. 2012b). Since VACV late protein accumulation and progeny formation were impaired in Rac1-N17 DN cells, we concluded that Rac1 role takes place earlier than the progeny exit step. We also concluded that the defects in VACV replication in Rac1-N17 DN cells are associated to the reduced Akt activation early in infection rather than to Rac1 participation in JNK1/2 signalling pathway.

Initial and recent studies have demonstrated that Rac1 is activated at early times during VACV infection and it plays a role in viral entry. Furthermore, staurosporine (non-specific inhibitor of protein kinases), genistein (tyrosine kinases inhibitor), wortmannin (PI3K inhibitor) and EIPA (selective inhibitor of Na+/H+ exchange) prevented Rac1 activation upon VACV infection; however, when cells were transfected with a constitutive active form of Rac1 viral entry was restored only in the presence of staurosporine and genistein, but not wortmannin or EIPA. These results suggest that activation of Rac1 itself is not enough to guarantee viral entry, but it contributes to it ([@B39], [@B41]). Our results indicate that reduction of viral yield during VACV infection may be not related to the total impairment of viral entry since we were able to detect early gene expression at the same levels in A31 and DN Rac1-N17 cell lines.

In summary, our studies revealed that the small GTPase Rac1 plays an important role during VACV replication by participating in the signalling pathway of PI3K/Akt, which may contribute to cell survival and consequently to a productive viral infection; however, this feature cannot be extended to CPXV. Therefore, further investigations are required to address if CPXV activates another GTPase and its participation in cellular signalling pathways activated upon infection as well as viral entry. By uncovering the components that participate in the cellular signalling pathways activated by those two phylogenetically close orthopoxviruses, a better understanding about the relevance of these events for viral life cycle will be established.
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